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Purpose: To fabricate ketoprofen transdermal patches (KTPs) using an acrylic pressure-sensitive 
adhesive (PSA) polymer.  
Methods: KTPs were prepared using solvent casting method. The influence of the amount of PSA, drug 
content, and terpenes as penetration enhancers on the characteristics of the patch, namely, thickness, 
W/A ratio, and adhesiveness and in vitro skin permeation, were investigated. Scanning electron 
microscope (SEM) and differential scanning calorimetry (DSC) studies were also performed on the 
patches. The physical and chemical stability of KTPs after storage at 40 oC, and 75 %RH for 1 month 
was also evaluated.  
Results: DSC thermograms demonstrate that the drug was dispersed molecularly in the polymer in all 
the formulations. Increase in PSA content increased the W/A ratio and adhesiveness of KTPs. 
Ketoprofen release from the transdermal patches followed the Higuchi diffusion model. Ketoprofen flux 
increased with increase in the ketoprofen content of the adhesive matrix.  Inclusion of terpenes in the 
patch formulations significantly increased the permeation of ketoprofen through the skin, with 
enhancement ratio (ER) ranging from 1.4 to 2.6.  
Conclusion: KTPs formulated with acrylic pressure-sensitive adhesive and incorporating terpenes as 
permeation enhancers demonstrated suitable characteristics for transdermal delivery of ketoprofen. 
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INTRODUCTION 
 
Ketoprofen (KP) is a non-steroidal anti-
inflammatory and analgesic drug. KP causes 
gastrointestinal irritation when administered 
orally. One promising method to reduce this 
adverse effect is to deliver the drug through 
the skin. Various methods have been tried to 
enhance the delivery of KP through the skin 
including the use of liposomes, penetration 
enhancers and microemulsions [1-5]. 
 
Some ketoprofen transdermal patches 
(KTPs) have been developed by previous 
researchers. Okabe et al [6] reported that, 
among various polymer types, acrylic 
polymer resulted in the highest flux for KP. 
Adachi et al [7] found that a polymer matrix 
made up of styrene-isoprene-styrene (SIS) is 
an excellent material for the preparation of 
KTPs with good adhesiveness and skin 
permeation. Although various systems for the 
preparation of ketoprofen transdermal drug 
delivery devices have been reported in the 
literature [6-8], better systems that would 
result in improved patch stability and high 
skin permeation of KP are still required. 
 
The objective of this work was to evaluate the 
effect of formulation factors, such polymer 
and drug content, and penetration enhancers, 
on the physicochemical properties and skin 







Acrylic pressure-sensitive adhesive (Acrylax® 
ER-7306), siliconized paper and polyolefin 
backing membrane were gifts from Neoplast 
Co, Ltd, Patumthani, Thailand. Ketoprofen, 
indomethacin, and penetration enhancers 
(limonene, menthone and -pinene) were 
obtained from Sigma Chemicals, St Louis, 
MO, USA. Commercial ketoprofen trans-
dermal patch (Mohrus®, Hitsamitsu Co, Ltd) 
was purchased from Tokyo, Japan. All other 
chemicals and solvents used were of 
analytical reagent grade. 
 
Preparation of ketoprofen transdermal 
patch (KTP) 
 
The composition of the KTPs is shown in 
Table 1. For each preparation, different 
proportions of ketoprofen alone or in 
combination with penetration enhancers 
(limonene, -pinene and menthone) were 
thoroughly mixed with acrylic PSA (solid 
content 45% w/w) in a glass tube. The 
mixture was poured on a sheet (10 x 20 cm) 
of polyolefin backing membrane that had 
been fixed onto a clean glass plate. The 
thickness of KTPs was controlled with a thin-
layer chromatographic (TLC) plate scraper 
(Camag, Switzerland). The gap between the 
scraper and backing membrane was fixed at 
0.5 mm. The film was dried at 50 C in a hot 
air oven for 1 h and then covered with 
siliconized release liner. The sheets of dried 
ketoprofen adhesive laminates were wrapped 
in aluminum foil and stored at 8 oC in a 
refrigerator. 
 
Measurement of patch thickness and 
weight/area ratio 
 
The thickness of the patch was measured 
using an electronic digital caliper (Ultracal IV 
 
Table 1: Composition of the ketoprofen transdermal patches 
 
 Ingredient (g) F1 F2 F3 F4 F5 F6 F7 F8 
Ketoprofen 0.9 1.8 3.6 1.8 1.8 1.8 1.8 1.8 
Acrylic PSA 100 100 100 50 200 100 100 100 
-pinene - - - - - 5 - - 
Limonene      - 5 - 
Menthone        5 
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Ted Pella, USA). The thickness of the 
adhesive matrix was determined as the 
difference in thickness between the patch 
with backing membrane and siliconized 
release liner together on the one hand, and 
the backing membrane and siliconized 
release liner, on the other. The weight/area 
(W/A) ratio of the patch was also determined. 
The patch (1 cm x 1 cm) was cut and 
weighed accurately. The difference between 
the weight of ketoprofen patch and the weight 
of backing membrane divided by area 
provided the W/A ratio of the patch. 
 
Scanning electron microscopy (SEM) 
studies 
 
The surface morphology of ketoprofen 
adhesive matrix film was characterized. by 
SEM. A sample of the patch was mounted on 
aluminum stubs using a two-sided adhesive 
tape, gold-coated in a vacuum evaporator, 
and photographed using a scanning electron 
microscope (Maxim MX 2000, Camtrad, 
England) 
 
Differential scanning calorimetry (DSC) 
studies 
 
Thermal analysis was performed with a 
Sapphire DSC (Perkin Elmer, MA, USA). The 
sample (ketoprofen powder, adhesive or 
patch) weighing about 2 mg was placed in a 
crimped aluminum pan, sealed with a 
perforated lid and heated from -30 to 200 0C 
at a heating rate of 10 0C/min. The 
measurement was carried out under nitrogen 
atmosphere at a flow rate of 100 mL/min. 
 
Evaluation of adhesive property 
 
The adhesiveness of the transdermal patches 
was measured by a texture analyzer (TA.XT 
plus, NY, USA) equipped with rounded 
spherical ball probe. 
 
Patches were cut into strips (2 cm diameter) 
and applied to an adherent plate made of 
stainless steel; it was smoothened with a 2 kg 
roller 3 times, and pulled from the substrate 
at an angle of 180° at a rate of 5 mm/s. The 
measurement of the adhesiveness was 




The patches were stored at 40 0C and 75 % 
relative humidity (RH) for 30 days. Both 
physical and chemical stability of KP were 
evaluated. Chemical stability was determined 
by measuring KP content by HPLC (as 
described below) on days 0, 7, 15, and 30. 
Physical stability was assessed by examining 
for the presence of crystalline drug on the 
patch by SEM. 
 
Evaluation of in vitro skin permeation of 
the patches 
 
Shed snake skin of Naja khaothia was kindly 
donated by the Queen Saowabha Memorial 
Institute, Thai Red Cross Society, Bangkok, 
Thailand).  It was used as a model 
membrane because of the similarities of its 
permeability to that of human skin [9]. It was 
obtained from 7 snakes. . Each skin can be 
divided into 10 - 12 pieces. The thickness of 
the skins ranged from 0.02 - 0.03 mm, and 
was stored at -10 0C prior to use. In vitro 
permeation experiments were performed 
using a Franz diffusion cell (MatTek 
Corporation, California, USA). The skin was 
mounted between the donor and receptor 
phases of the diffusion cell. The temperature 
of the receptor solution was maintained at 37 
± 0.5 oC using a water jacket connected to a 
water bath. The receptor chamber had a 
volume 15.0 ml volume with an effective 
diffusion area of 12.6 cm2.  The patch was 
placed on a piece of the snake skin, which, in 
turn was placed on top of pH 7.4 phosphate 
buffered saline (PBS) in the receptor 
chamber of diffusion cell. The receptor cell 
was stirred at 600 rpm with a star-head 
Teflon magnetic bar (Nalge Nunc 
International Co., Ltd., Minnesota, USA) 
driven by a synchronous motor. At 
predetermined time intervals, 0.5 ml of 
sample was taken from the receptor 
compartment and replaced with the same 
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volume of fresh PBS.  All experiments were 
carried out in triplicate. The samples were 
stored at 4 °C until analysis by HPLC. The 
cumulative amount of KP was plotted against 
time, and steady state flux was determined 
from the slope of the plots by linear 
regression analysis. The intercept on the X-
axis was determined as the lag time (TL, h). 
In order to evaluate effect of permeation 
enhancer, the enhancement ratio (ER) was 
determined as in Eq 1. 
ER = Fe/Fo    …………….. (1) 
where Fe is the flux from the formulation with 
enhancer and Fo is the flux from the 
formulation without enhancer  
 
Determination of ketoprofen content 
 
A Perkin Elmer Series 2000 HPLC (Perkin 
Elmer, USA) was used to quantify the amount 
of KP. Chromatographic separation of KP 
was achieved using a symmetric C18 column 
(Perkin Elmer, Massachusetts, USA, particle 
size = 5 μm; column dimension = 4.6 x 150 
mm) operating at a flow rate of 1 ml min-1. 
The mobile phase comprised of 0.1 %v/v 
phosphoric acid: methanol (25:75, v/v). 
Indomethacin was used as internal standard. 
The injection volume was 20 μl, and the UV 
detector was set at 254 nm. All the sample 
solutions were filtered through a 
polytetrafluoroethylene (PTFE) filter (mean 
pore size = 0.45 m) prior to injection. The 
calibration curve for KP was based on the 
range of 1 - 50 g ml-1 with a correlation 
coefficient of 0.998. Intra-day and inter-day 
percent relative standard deviation (% RSD) 




All experimental measurements were carried 
out in triplicate. The results are expressed as 
mean ± standard deviation (SD). Statistical 
significance of difference (p < 0.05) for 
steady state flux was examined using 
analysis of variance (ANOVA) with post-hoc 
test. SigmaStat software (version 3.5, 





Characteristics of KTPs 
 
The characteristics of the KTPs are shown in 
Table 2. All the KTPs were colourless, 
transparent, free of air bubbles, and had a 
smooth surfaces. SEM showed that there 
was no precipitation in the patches. 
Thickness and W/A ratio data for the 
ketoprofen patches showed low standard 
deviation (SD), indicating good reproducibility 
in their preparation. The thickness of the 
patches was in the range 102 - 104 m, 
compared with 20 m for the commercial 
patch, due to the difference in the 
composition and preparation methods of the 
test and commercial patch.  W/A ratio in the 
range of 5 - 19 mg/cm2 was recorded for the 
test patches, while adhesiveness was 0.22 - 
0374 N/cm. Increase in KP content (F1 - F3) 
and incorporation of terpenes (as penetration 
enhancers) in the patches (F6 - F8) did not 
alter W/A ratio and adhesiveness of the 
KTPs.  However, as the content of PSA in the 
patch increased, W/A ratio and adhesiveness 




The DSC thermograms of ketoprofen powder, 
PSA and ketoprofen transdermal patches are 
shown in Figure1. Ketoprofen powder 
showed an endothermic peak at about 96 C, 
but no similar peak was found for PSA and 
ketoprofen transdermal patch (F1, F2 and 
F3). 
 
Stability of KTPs. 
 
Chemical stability data (expressed as percent 
KP remaining in the patch) of the KTPs are 
presented in Fig 2. KP remaining after 
storage at 40 0C / 75 %RH for 30 days was in 
the range 90 - 95 %.   There was no  
 
Ngawhirunpat et al 
Trop J Pharm Res, August 2012;11 (4): 557 
















F1 0.14±0.02 1.43±0.01 102.6±4.3   9.9±0.5 0.485±0.075 0.66±0.03 0.71±0.03 
F2 0.29±0.02 2.84±0.01 102.6±4.3 10.2±0.2 0.462±0.095 1.33±0.12 0.67±0.02 
F3 0.45±0.03 4.41±0.04 102.6±4.3 10.1±0.3 0.448±0.104 2.62±0.21 0.74±0.06 
F4 0.29±0.04 2.84±0.02 102.6±4.3   5.1±0.3 0.228±0.081 0.74±0.07 0.52±0.04 
F5 0.29±0.04 2.84±0.01 102.6±4.3 19.2±0.1 0.741±0.079 2.23±0.18 0.61±0.03 
F6 0.30±0.02 2.85±0.02 102.6±4.3 10.4±0.9 0.426±0.076 3.43±0.31 0.53±0.03 
F7 0.29±0.02 2.85±0.02 102.6±4.3 10.2±0.7 0.423±0.079 2.51±0.14 0.61±0.02 
F8 0.29±0.01 2.85±0.01 102.6±4.3 10.1±0.8 0.428±0.090 1.84±0.11 0.57±0.01 
Commercial  




Figure 1:  DSC thermogram of KTP and its major 
components 
 
Figure 2:  KP content (mean ± SD, n = 3) of 
patches after storage at 40 0C / 75 %RH over a 
30-day period.  
Key: (●) F1, (○) F2, (▲) F3, (∆) F4, (■) F5, (□) F6, 
(♦) F7, and (◊) F8. 
        
In vitro skin permeation of KTPs 
 
The snake skin permeation profile of 
ketoprofen from different formulations of 
ketoprofen transdermal patches is presented 
in Figure 3. The permeation parameters (flux 
and lag time) of ketoprofen are summarized 
in Table 2. The plot of the amount of 
ketoprofen that have permeated the skin 
layer and square root of time are linear with a 
correlation coefficient (R2 > 0.98), and a short 
lag time. Ketoprofen flux increased when 
ketoprofen content of the patch increased 
from 0.14 (F1) through 0.29 mg/cm2 (F2), to 
0.45 mg/cm2 (F3) (Fig 3a), showing a 
correlation coefficient (R2) > 0.99. However, 
ketoprofen flux decreased significantly (p < 
0.05), when PSA content of the patch 
increased (Fig. 3b). There was no significant 
difference between the KP flux of F2 and the 
commercial (reference) patch (Fig 3c, Table 
2). Incorporation of penetration enhancers (-
pinene, limonene or menthone) in the 
patches increased KP flux (Figure 3c, Table 
2). The presence of terpene enhancers 
produced a 1.4- to 2.6-fold flux increase (F6 - 
F8) over the patch without any terpene (F2). 
Among the terpenes, -pinene showed the 
highest ER for the patches; ER was in the 
rank order: -pinene >limonene >menthone. 
The lag time of the KTPs (F1 - F8) was not 
significantly different (p > 0.05). 
Ngawhirunpat et al 




















































Figure 3: Permeation of ketoprofen from KTPs: (a) 
(♦) F1, ( ) F2 and (▲) F3: (b) ( ) F2, (●) F4, and 
(◊) F5; and (c) ( ) F2, (■) commercial (reference) 
patch, (○) F6, (♦) F7, and (∆) F8 through shed 




KTPs using acrylic pressure sensitive 
adhesive as matrix and terpene as skin 
penetration enhancers have been 
successfully developed in the present study. 
Acrylates are saturated polymers and are 
resistant to oxidation, and therefore, does not 
undergo colour change upon exposure to 
sunlight [10]. of the developed KTPs 
demonstrated suitable characteristics they 
were colourless, transparent, free of air 
bubbles, smooth and without evident 
precipitation of drug. Moreover, good physical 
and chemical stability was obtained.   
 
Increase in PSA content enhanced the 
adhesiveness of the patch as a result of the 
higher cohesive force between the polymers. 
The DSC endotherm indicated a transition for 
KP between 90 to 100 oC, due probably to 
solid to liquid transition since the melting 
point of KP is 94 oC. Since pure PSA and the 
PSA incorporated with KP did not show any 
endothermic peak in this region, it can be 
said that there was no interaction between 
the drug and the polymer.  
 
The high correlation coefficient between 
ketoprofen permeation and square root of 
time indicates that the patch-skin system 
formed a single homogeneous polymeric film 
[11]. Ketoprofen flux increased when 
ketoprofen content in the patches was 
increased. These results are similar to those 
obtained for nicotine acrylic patch [11,12].  
The higher the ketoprofen content of the 
patch, the higher the diffusion activity of the 
drug; furthermore, the higher drug content 
reduces the relative amount polymer matrix, 
thus lowering the diffusional barrier to the 
drug. Ketoprofen flux decreased when PSA 
content increased due to the fact that 
increase in the latter also increased the 
diffusion barrier of the polymer matrix to KP 
permeation [13].  
 
The possible mechanism of terpene 
enhancement of KP permeation may be 
disruption in skin morphology as a result of 
the lipid fluidizing activity of terpenes [14].  
Terpenes are known to extract lipids from 
stratum corneum [15], resulting in disorder of 
lipid domains. Moreover, terpenes also 
facilitate drug diffusion by increasing 
partitioning of the drugs into the stratum 
corneum [16]. The difference in the 
permeation enhancement ratios of the 
terpenes may be linked to differences in their 
molecular weights and boiling points. Thus, 
-pinene and limonene exhibited higher 
penetration enhancement than menthone 
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because of their lower boiling points and 
molecular weights. Low boiling point of a 
terpene indicates there is weak cohesiveness 
or self-association of the molecules [17], and 
therefore they are likely to more easily 
associate or interact with the lipid 
components of the stratum corneum and alter 
hence alter its barrier property. Our results 
were consistent with those of Narishetty & 
Panchagnula [18] who reported that for 
hydrophobic drugs such as indomethacin, 
lipophilic terpenes, such as limonene, were 
effective enhancers.  
 
The lag time of the KTPs formulations was 
not significantly different with respect to the 
terpene type.  This finding is in agreement 
with that of of Maghraby [19]. The lag time is 
a permeation parameter that depends mainly 
on drug diffusivity through skin. However, it 
does not depend directly on the drug release. 
The absence of a significant lag time 
confirms that skin permeation of KP is not 




KTPs prepared acrylic PSA were successfully 
developed. The patches showed good 
physical and chemical stability as well as 
satisfactory permeation characteristics. 
However, in vivo studies are required to 
determine the patch’s actual suitability for 
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